Cryptococcus neoformans pulmonary granuloma formation is associated with matrix metalloproteinase-2 expression

Medical Mycology

Volumn 40, Issue 3, 2002, Pages 323-328

  Majka, S M ^a   Kasimos, J ^b   Izzo, L ^b   Izzo, A A ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

C. neoformans; Granuloma; MMP 2; TIMP 2

Indexed keywords

CYTOKINE; GELATINASE A; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DISEASE CLASSIFICATION; IMMUNE RESPONSE; LEUKOCYTE; LUNG CARCINOGENESIS; LUNG GRANULOMA; LUNG MYCOSIS; MOUSE; NONHUMAN; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; CRYPTOCOCCOSIS; DISEASE MODEL; GENETICS; IMMUNOLOGY; LEUKOCYTE COUNT; LUNG; METABOLISM; MICROBIOLOGY; TIME;

ANIMALIA; FILOBASIDIELLA NEOFORMANS;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; GRANULOMA, RESPIRATORY TRACT; LEUKOCYTE COUNT; LUNG; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; RNA, MESSENGER; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0036305367     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.40.3.323.328     Document Type: Article

References (25)

1. Protective cell-mediated immunity against Cryptococcus neoformans
2. Therapy for cryptococcal meningitis in patients with AIDS
3. Pulmonary cryptococcosis
4. Cells and cytokines in pulmonary cryptococcosis
5. Factors regulating effective T-cell immunity in the lung
6. T cell-mediated immunity in the lung: A Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice
7. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice
8. IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice
9. Proteolytic remodeling of extracellular matrix
10. Matrix metalloproteinases in immunity
11. Metalloproteinase-mediated regulation of L-selectin levels on leucocytes
12. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema
13. Matrix metalloproteinases
14. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
15. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases
16. Bacterial phospholipase C upregulates matrix metalloproteinase expression by cultured epithelial cells
17. The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes
18. Monocytic cell type-specific transcriptional induction of collagenase
19. Characterization of matrix metalloproteinases produced by rat alveolar macrophages
20. Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury
21. Expression of PZ-peptidases by cultures of several pathogenic fungi. Purification and characterization of a ollagenase from Trichophyton schoenleinii
22. The new kids on the block: ADAMTSs, potentially multifunctional metalloproteinases of the ADAM family
23. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-α, granulocyte-macrophage CSF, and IL-1β through prostaglandin-dependent and -independent mechanisms
24. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
25. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans